Global Immuno-oncology Drugs Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Immuno-oncology Drugs

• 1.1 Definition of Immuno-oncology Drugs
• 1.2 Immuno-oncology Drugs Segment by Type
  • 1.2.1 Global Immuno-oncology Drugs Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Immune Checkpoint Inhibitors
  • 1.2.3 Monoclonal Antibodies
  • 1.2.4 Cytokine-Based Immunotherapy
  • 1.2.5 Cancer Vaccines
  • 1.2.6 CAR-T Cell Therapy
• 1.3 Immuno-oncology Drugs Segment by Applications
  • 1.3.1 Global Immuno-oncology Drugs Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospitals
  • 1.3.3 Pharmacies
  • 1.3.4 Online Pharmacies
• 1.4 Global Immuno-oncology Drugs Overall Market
  • 1.4.1 Global Immuno-oncology Drugs Revenue (2014-2025)
  • 1.4.2 Global Immuno-oncology Drugs Production (2014-2025)
  • 1.4.3 North America Immuno-oncology Drugs Status and Prospect (2014-2025)
  • 1.4.4 Europe Immuno-oncology Drugs Status and Prospect (2014-2025)
  • 1.4.5 China Immuno-oncology Drugs Status and Prospect (2014-2025)
  • 1.4.6 Japan Immuno-oncology Drugs Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Immuno-oncology Drugs Status and Prospect (2014-2025)
  • 1.4.8 India Immuno-oncology Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Immuno-oncology Drugs
• 2.3 Manufacturing Process Analysis of Immuno-oncology Drugs
• 2.4 Industry Chain Structure of Immuno-oncology Drugs

3 Development and Manufacturing Plants Analysis of Immuno-oncology Drugs

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Immuno-oncology Drugs Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Immuno-oncology Drugs
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Immuno-oncology Drugs Production and Capacity Analysis
• 4.2 Immuno-oncology Drugs Revenue Analysis
• 4.3 Immuno-oncology Drugs Price Analysis
• 4.4 Market Concentration Degree

5 Immuno-oncology Drugs Regional Market Analysis

• 5.1 Immuno-oncology Drugs Production by Regions
  • 5.1.1 Global Immuno-oncology Drugs Production by Regions
  • 5.1.2 Global Immuno-oncology Drugs Revenue by Regions
• 5.2 Immuno-oncology Drugs Consumption by Regions
• 5.3 North America Immuno-oncology Drugs Market Analysis
  • 5.3.1 North America Immuno-oncology Drugs Production
  • 5.3.2 North America Immuno-oncology Drugs Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Immuno-oncology Drugs Import and Export
• 5.4 Europe Immuno-oncology Drugs Market Analysis
  • 5.4.1 Europe Immuno-oncology Drugs Production
  • 5.4.2 Europe Immuno-oncology Drugs Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Immuno-oncology Drugs Import and Export
• 5.5 China Immuno-oncology Drugs Market Analysis
  • 5.5.1 China Immuno-oncology Drugs Production
  • 5.5.2 China Immuno-oncology Drugs Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Immuno-oncology Drugs Import and Export
• 5.6 Japan Immuno-oncology Drugs Market Analysis
  • 5.6.1 Japan Immuno-oncology Drugs Production
  • 5.6.2 Japan Immuno-oncology Drugs Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Immuno-oncology Drugs Import and Export
• 5.7 Southeast Asia Immuno-oncology Drugs Market Analysis
  • 5.7.1 Southeast Asia Immuno-oncology Drugs Production
  • 5.7.2 Southeast Asia Immuno-oncology Drugs Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Immuno-oncology Drugs Import and Export
• 5.8 India Immuno-oncology Drugs Market Analysis
  • 5.8.1 India Immuno-oncology Drugs Production
  • 5.8.2 India Immuno-oncology Drugs Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Immuno-oncology Drugs Import and Export

6 Immuno-oncology Drugs Segment Market Analysis (by Type)

• 6.1 Global Immuno-oncology Drugs Production by Type
• 6.2 Global Immuno-oncology Drugs Revenue by Type
• 6.3 Immuno-oncology Drugs Price by Type

7 Immuno-oncology Drugs Segment Market Analysis (by Application)

• 7.1 Global Immuno-oncology Drugs Consumption by Application
• 7.2 Global Immuno-oncology Drugs Consumption Market Share by Application (2014-2019)

8 Immuno-oncology Drugs Major Manufacturers Analysis

• 8.1 Amgen, Inc
  • 8.1.1 Amgen, Inc Immuno-oncology Drugs Production Sites and Area Served
  • 8.1.2 Amgen, Inc Product Introduction, Application and Specification
  • 8.1.3 Amgen, Inc Immuno-oncology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 AstraZeneca, Plc
  • 8.2.1 AstraZeneca, Plc Immuno-oncology Drugs Production Sites and Area Served
  • 8.2.2 AstraZeneca, Plc Product Introduction, Application and Specification
  • 8.2.3 AstraZeneca, Plc Immuno-oncology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Bristol-Myers Squibb
  • 8.3.1 Bristol-Myers Squibb Immuno-oncology Drugs Production Sites and Area Served
  • 8.3.2 Bristol-Myers Squibb Product Introduction, Application and Specification
  • 8.3.3 Bristol-Myers Squibb Immuno-oncology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Celgene Corporation
  • 8.4.1 Celgene Corporation Immuno-oncology Drugs Production Sites and Area Served
  • 8.4.2 Celgene Corporation Product Introduction, Application and Specification
  • 8.4.3 Celgene Corporation Immuno-oncology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Eli Lilly and Company
  • 8.5.1 Eli Lilly and Company Immuno-oncology Drugs Production Sites and Area Served
  • 8.5.2 Eli Lilly and Company Product Introduction, Application and Specification
  • 8.5.3 Eli Lilly and Company Immuno-oncology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Merck & Co.
  • 8.6.1 Merck & Co. Immuno-oncology Drugs Production Sites and Area Served
  • 8.6.2 Merck & Co. Product Introduction, Application and Specification
  • 8.6.3 Merck & Co. Immuno-oncology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Hoffmann-La Roche AG
  • 8.7.1 Hoffmann-La Roche AG Immuno-oncology Drugs Production Sites and Area Served
  • 8.7.2 Hoffmann-La Roche AG Product Introduction, Application and Specification
  • 8.7.3 Hoffmann-La Roche AG Immuno-oncology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Johnson & Johnson
  • 8.8.1 Johnson & Johnson Immuno-oncology Drugs Production Sites and Area Served
  • 8.8.2 Johnson & Johnson Product Introduction, Application and Specification
  • 8.8.3 Johnson & Johnson Immuno-oncology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Novartis International AG
  • 8.9.1 Novartis International AG Immuno-oncology Drugs Production Sites and Area Served
  • 8.9.2 Novartis International AG Product Introduction, Application and Specification
  • 8.9.3 Novartis International AG Immuno-oncology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 AbbVie, Inc.
  • 8.10.1 AbbVie, Inc. Immuno-oncology Drugs Production Sites and Area Served
  • 8.10.2 AbbVie, Inc. Product Introduction, Application and Specification
  • 8.10.3 AbbVie, Inc. Immuno-oncology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Pfizer Inc.
• 8.12 Sanofi S.A.
• 8.13 EMD Serono, Inc.
• 8.14 Gilead Sciences Inc.
• 8.15 Prometheus Therapeutics & Diagnostics
• 8.16 Aduro BioTech
• 8.17 Galena Biopharma
• 8.18 Bavarian Nordic
• 8.19 Celldex Therapeutics
• 8.20 ImmunoCellular Therapeutics
• 8.21 Incyte

9 Development Trend of Analysis of Immuno-oncology Drugs Market

• 9.1 Global Immuno-oncology Drugs Market Trend Analysis
  • 9.1.1 Global Immuno-oncology Drugs Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Immuno-oncology Drugs Regional Market Trend
  • 9.2.1 North America Immuno-oncology Drugs Forecast 2019-2025
  • 9.2.2 Europe Immuno-oncology Drugs Forecast 2019-2025
  • 9.2.3 China Immuno-oncology Drugs Forecast 2019-2025
  • 9.2.4 Japan Immuno-oncology Drugs Forecast 2019-2025
  • 9.2.5 Southeast Asia Immuno-oncology Drugs Forecast 2019-2025
  • 9.2.6 India Immuno-oncology Drugs Forecast 2019-2025
• 9.3 Immuno-oncology Drugs Market Trend (Product Type)
• 9.4 Immuno-oncology Drugs Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Immuno-oncology Drugs Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List